🎁 Black Friday: up to 50% off of annual plans
SciVision Biotech Inc. (TPE:1786)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
40.35
-1.35 (-3.24%)
Nov 20, 2026, 1:30 PM CST

SciVision Biotech Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
870.41886.62883.31712.99557.35505.54
Revenue Growth
-2.25%0.38%23.89%27.93%10.25%8.28%
Cost of Revenue
255.63248.23227.63200.49185.48163.7
Gross Profit
614.78638.39655.68512.49371.87341.84
Selling, General & Admin
383.04355.28346.86259.44184.8153.95
Research & Development
98.9193.1960.7153.4252.4665.94
Operating Expenses
481.95448.47407.57312.86237.26219.89
Operating Income
132.83189.92248.11199.64134.61121.94
Interest Expense
-12.5-7.93-5.67-8.22-6.46-8.07
Interest & Investment Income
27.124.4220.6114.94.882.63
Currency Exchange Gain (Loss)
-19.24-19.2420.48-0.5111.81-1.46
Other Non Operating Income (Expenses)
33.840.011.430.750.171.01
EBT Excluding Unusual Items
162.04187.18284.96206.56145.02116.05
Gain (Loss) on Sale of Investments
-2.13-2.136.452.9-1.98-0.13
Gain (Loss) on Sale of Assets
-0.01-0.010.190.5430.550.13
Other Unusual Items
-----0.04-
Pretax Income
159.9185.04291.6210173.55116.06
Income Tax Expense
17.0822.749.3432.131.8314.34
Net Income
142.82162.34242.25177.9141.72101.72
Net Income to Common
142.82162.34242.25177.9141.72101.72
Net Income Growth
-13.30%-32.99%36.17%25.53%39.32%-20.53%
Shares Outstanding (Basic)
747269676666
Shares Outstanding (Diluted)
787774767571
Shares Change
5.55%3.33%-2.58%2.39%5.18%0.61%
EPS (Basic)
1.932.243.512.662.141.54
EPS (Diluted)
1.902.183.302.411.921.51
EPS Growth
-15.10%-34.03%37.15%25.26%27.30%-20.11%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-4.1622.46235.11257.28167.0372.73
Free Cash Flow Per Share
-0.050.293.163.372.241.02
Dividend Per Share
1.9101.9103.2502.5002.0001.420
Dividend Growth
-41.23%-41.23%30.00%25.00%40.84%60.49%
Gross Margin
70.63%72.00%74.23%71.88%66.72%67.62%
Operating Margin
15.26%21.42%28.09%28.00%24.15%24.12%
Profit Margin
16.41%18.31%27.43%24.95%25.43%20.12%
Free Cash Flow Margin
-0.48%2.53%26.62%36.08%29.97%14.39%
EBITDA
213.46260.13310.17261.42195.35173.08
EBITDA Margin
24.52%29.34%35.12%36.66%35.05%34.24%
D&A For EBITDA
80.6370.2162.0661.7860.7451.14
EBIT
132.83189.92248.11199.64134.61121.94
EBIT Margin
15.26%21.42%28.09%28.00%24.15%24.12%
Effective Tax Rate
10.68%12.27%16.92%15.29%18.34%12.35%